FDA ap­proves first over-the-counter birth con­trol pill, ex­pect­ed to hit shelves in 2024

The FDA has ap­proved the first over-the-counter birth con­trol pill, Per­ri­go’s Opill, clear­ing the way for con­sumers to eas­i­ly ac­cess the con­tra­cep­tive at drug stores, con­ve­nience stores and on­line.

The drug will hit shelves in ear­ly 2024, Per­ri­go’s glob­al VP for women’s health Frédérique Wel­gryn said in a me­dia brief­ing Thurs­day morn­ing. Wel­gryn de­clined to com­ment on the an­tic­i­pat­ed price but said more in­for­ma­tion will be avail­able in the com­ing months.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER